Lukas Utiger, Ph.D

Dr. Utiger is President of the drug substance network and pharmaceutical development service at Patheon. Most recently, he served as President and CEO of the DSM Pharmaceutical Products and DPx Fine Chemicals. Before joining DSM in 2013, Dr. Utiger served as Chief Operating Officer of the bioscience division at Lonza Group AG. Prior to that, he served as Chief Operating Officer of the company’s life science ingredients division, Head of the exclusive synthesis business sector, and Head of Research and Development for Exclusive Synthesis. He joined Lonza in 1992 as an R&D Chemist and advanced to Group Leader for fine chemicals in 1998. Dr. Utiger began his career at ICI chemicals & polymers division in 1988. He earned his Ph.D. in chemical engineering at Imperial College, London.